Fidelity Biosciences (United States)

Recent papers from Fidelity Biosciences (United States)

1. Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue)Cancer Cytopathology · 2026
2. Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utilityJournal of Controlled Release · 2026
3. Abstract 2604: Postoperative lymphatic exudate as a proximal liquid biopsy source in muscle-invasive bladder cancerCancer Research · 2026
4. Abstract 814: Lymphatic exudate is a novel source of tumor-associated immune cells.Cancer Research · 2026
5. Abstract 6925: Leveraging AI-enhanced multi-omics discovery of novel tumor-selective targets for ADC developmentCancer Research · 2026
6. Alzheimer's disease Stage 1 and 2: Biology, diagnostics, and treatmentAlzheimer s & Dementia Translational Research & Clinical Interventions · 2026
7. Aspyre Lung enables robust variant calling in samples that fail next generation sequencing quality controlTranslational Oncology · 2025
8. Novel electroencephalographic biomarkers for the prediction of responders to an experimental glutamatergic agent in patients with schizophreniaTranslational Psychiatry · 2025
9. A community-led initiative to de-risk and advance Parkinson’s disease therapeutic targetsnpj Parkinson s Disease · 2025
10. Analytical validation of Aspyre Clinical Test for Lung (Blood): A multiplexed PCR and pyrophosphorolysis-based assay for detecting actionable NSCLC variants in plasma cfDNA and cfRNAThe Journal of Liquid Biopsy · 2025
11. Benefits of aggressively co-undergrounding electric and broadband lines outweigh costsCell Reports Sustainability · 2025
12. Combinatorial effector targeting (COMET) for transcriptional modulation and locus-specific biochemistry2024
13. A framework and methodology for analyzing technology spillover processes with an application in solar photovoltaicsTechnovation · 2024
14. Efficient prime editing in two-cell mouse embryos using PEmbryoNature Biotechnology · 2024
15. Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-CasThe CRISPR Journal · 2024
16. Serum lipoproteins and lipoarabinomannan suppress the inflammatory response induced by the mycolactone toxin2022
17. Statistical considerations in clinical trial design with event‐free survival as the primary efficacy endpointPharmaceutical Statistics · 2021
18. Synthesis of the Nakanishi Ring-Locked RetinoidInternational Journal of Medicinal Chemistry · 2011
19. Packet Trains--Measurements and a New Model for Computer Network TrafficIEEE Journal on Selected Areas in Communications · 1986